sodium-bicarbonate and Esophageal-Diseases

sodium-bicarbonate has been researched along with Esophageal-Diseases* in 3 studies

Other Studies

3 other study(ies) available for sodium-bicarbonate and Esophageal-Diseases

ArticleYear
Effervescent agents in acute esophageal food impaction.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2019, Apr-01, Volume: 32, Issue:4

    Acute esophageal food impaction (AEFI) occurs frequently. Few data are published describing the use of effervescent agents (EAs) for treatment of AEFI. We aimed to evaluate the effectiveness, cost, and safety of EAs in the treatment of AEFI. We retrospectively identified patients aged 18 years and older who were seen in the emergency department of 2 hospitals in 1 metropolitan area from January 1, 2011, through April 4, 2016, who had a clinical diagnosis of AEFI. We collected and analyzed data on outcomes and cost associated with the use of EAs, glucagon, and no pharmacologic therapy. During the study period, 239 patients with AEFI met the inclusion criteria. Of the 45 patients who received EA monotherapy, 25 (55.6%) responded successfully, compared with 11 of 62 (17.7%) who received glucagon monotherapy (P < .001) and 16 of 93 (17.2%) who had no therapy (P < .001). Ten of 39 patients (25.6%) who were given both glucagon and EA responded successfully. The other 177 patients had endoscopy, which was successful in all cases. Median hospitalization charges for patients who responded successfully to EA alone were $1,136, compared with $2,602 for responders to glucagon alone (P < .001) and $1,194 for those who cleared their bolus spontaneously (P < .001). All patients who received EA monotherapy had lower median hospitalization costs ($2,384) than all patients who received glucagon monotherapy ($9,289; P = .03) and all patients who received neither ($8,386; P = .02). Effervescent agents are a safe, effective, and cost-saving initial strategy in the treatment of acute esophageal food impaction.

    Topics: Acute Disease; Citrates; Drug Combinations; Drug Therapy, Combination; Emergency Service, Hospital; Esophageal Diseases; Female; Food; Gastrointestinal Agents; Glucagon; Humans; Male; Middle Aged; Retrospective Studies; Sodium Bicarbonate; Treatment Outcome

2019
A case report of Boerhaave's syndrome following colonoscopy preparation.
    The Medical journal of Australia, 1993, Nov-15, Volume: 159, Issue:10

    Topics: Colonoscopy; Drug Combinations; Esophageal Diseases; Humans; Male; Middle Aged; Polyethylene Glycols; Potassium Chloride; Rupture, Spontaneous; Sodium Bicarbonate; Sodium Chloride; Sulfates; Therapeutic Irrigation; Vomiting

1993
Gulper's gullet.
    The New England journal of medicine, 1988, Aug-18, Volume: 319, Issue:7

    Topics: Aged; Aspirin; Beverages; Bicarbonates; Carbonated Beverages; Citrates; Drug Combinations; Esophageal Diseases; Esophageal Perforation; Humans; Ice; Male; Sodium Bicarbonate; Spasm

1988